Comparing the Efficacy of Tamsulosin and Silodosin in the Medical Expulsion Therapy for Ureteral Calculi

Overview

Journal J Clin Diagn Res

Specialty General Medicine

Date 2013 Oct 3

PMID 24086871

Citations 19

Authors

Sandeep Gupta

Bijit Lodh

Akoijam Kaku Singh

Khumukcham Somarendra

Kangjam Sholay Meitei

Sinam Rajendra Singh

Affiliations

Soon will be listed here.

Abstract

Background: Urolithiasis is a chronic disease of mankind, which has enormous public health importance and it accounts for a substantial economic burden on our society. Hence, it becomes all the more important to formulate cheaper and easier means for treating this condition. The past few years have seen a number of drugs being introduced and successfully used in the medical expulsion therapy of small, uncomplicated ureteral calculi, with each drug claiming to provide better results than the others. Ours is perhaps the first study which has compared the efficacy of tamsulosin and silodosin in the medical expulsion therapy for ureteral calculi.

Aims: To compare the efficacy of tamsulosin (0.4mg) vs silodosin (8mg), both in terms of the stone expulsion rate and the time to stone expulsion.

Settings And Design: A prospective and a randomized controlled study was conducted in the Department of Urology, Regional Institute of Medical Sciences (RIMS), Imphal, Manipur, India.

Material And Methods: From February to August 2012, 100 patients who were between the age group of 18-50 years, who had unilateral, uncomplicated middle or lower ureteral stones </= 1cm were enrolled and they were divided into two groups. Group 1 received tamsulosin (0.4mg) daily, whereas Group 2 received silodosin (8mg) daily for a maximum period of 4 weeks. The patients were followed up weekly or biweekly with imaging studies. The primary endpoint was the stone expulsion rate and the secondary endpoints were the stone expulsion time, the rate of the interventions and the side effects.

Statistical Analysis: The statistical analysis was performed by using the Student's t-test and the Chi-squared test. A p value of < 0.05 was considered to be statistically significant. The SPSS-16 software was used for the statistical analysis of the data.

Results: A spontaneous stone expulsion was observed in 58% of the patients in group 1 and in 82% of the patients in Group 2, which was statistically significant. There was also a significant difference between the groups with regards to the mean stone expulsion time. A lower analgesic use was found in Group 2.

Conclusion: In our study, silodosin was found to be clinically superior to tamsulosin, both in terms of the stone expulsion rate and the stone expulsion time.

Citing Articles

Comparative study between silodosin, tamsulosin, silodosin plus tadalafil, and tamsulosin plus tadalafil as a medical expulsive therapy for lower ureteral stones: a prospective randomized trial.

Dogha M, Sherif I, Madney Y, Harb H, Rabea H Int Urol Nephrol. 2025; .

PMID: 39792210 DOI: 10.1007/s11255-024-04356-3.

Efficacy of pre-operative silodosin on flexible ureteroscopy procedure: A randomized controlled study.

Shaher H, Sebaey A, Albaky A, Mahmoud M, Elaal A Arab J Urol. 2024; 21(4):267-272.

PMID: 38178945 PMC: 10763580. DOI: 10.1080/2090598X.2023.2208790.

Evaluation of the efficacy and safety of either or both mirabegron and silodosin, as a medical expulsive therapy for distal ureteric stones.

Abdel-Kader M, Sayed A, Sayed S, AbdelRazek M Int Urol Nephrol. 2023; 56(5):1605-1610.

PMID: 38041752 PMC: 11001674. DOI: 10.1007/s11255-023-03880-y.

Does preoperative silodosin administration facilitate ureteral dilatation during flexible ureterorenoscopy? A randomized clinical trial.

Diab T, El-Shaer W, Ibrahim S, El-Barky E, Abou Elezz A Int Urol Nephrol. 2023; 56(3):839-846.

PMID: 37902925 PMC: 10853317. DOI: 10.1007/s11255-023-03824-6.

A Comparison Between Silodosin and Tamsulosin for Medical Expulsive Therapy of Distal Ureteric Calculus.

Abdullah A, Gupta Y, Selvaraj S, Ganapathy R, Ilangovan A, Sivalingam S Cureus. 2023; 15(10):e47008.

PMID: 37841986 PMC: 10576195. DOI: 10.7759/cureus.47008.

References

Pedro R, Hinck B, Hendlin K, Feia K, Canales B, Monga M . Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J Urol. 2008; 179(6):2244-7. DOI: 10.1016/j.juro.2008.01.141. View

Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K . Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol. 2007; 14(8):749-53. DOI: 10.1111/j.1442-2042.2007.01812.x. View

Wang C, Huang S, Chang C . Efficacy of an alpha1 blocker in expulsive therapy of lower ureteral stones. J Endourol. 2008; 22(1):41-6. DOI: 10.1089/end.2007.0133. View

Borghi L, Meschi T, Amato F, NOVARINI A, Giannini A, Quarantelli C . Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol. 1994; 152(4):1095-8. DOI: 10.1016/s0022-5347(17)32511-9. View

Malin Jr J, Deane R, BOYARSKY S . Characterisation of adrenergic receptors in human ureter. Br J Urol. 1970; 42(2):171-4. DOI: 10.1111/j.1464-410x.1970.tb10018.x. View

Parsons J, Hergan L, Sakamoto K, Lakin C . Efficacy of alpha-blockers for the treatment of ureteral stones. J Urol. 2007; 177(3):983-7. DOI: 10.1016/j.juro.2006.10.023. View

Hollingsworth J, Rogers M, Kaufman S, Bradford T, Saint S, Wei J . Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet. 2006; 368(9542):1171-9. DOI: 10.1016/S0140-6736(06)69474-9. View

Ibrahim A, Shetty S, Awad R, Patel K . Prognostic factors in the conservative treatment of ureteric stones. Br J Urol. 1991; 67(4):358-61. DOI: 10.1111/j.1464-410x.1991.tb15161.x. View

Tzortzis V, Mamoulakis C, Rioja J, Gravas S, Michel M, de la Rosette J . Medical expulsive therapy for distal ureteral stones. Drugs. 2009; 69(6):677-92. DOI: 10.2165/00003495-200969060-00003. View

10.

Seitz C, Liatsikos E, Porpiglia F, Tiselius H, Zwergel U . Medical therapy to facilitate the passage of stones: what is the evidence?. Eur Urol. 2009; 56(3):455-71. DOI: 10.1016/j.eururo.2009.06.012. View

11.

Daniels Jr G, Garnett J, Carter M . Ureteroscopic results and complications: experience with 130 cases. J Urol. 1988; 139(4):710-3. DOI: 10.1016/s0022-5347(17)42607-3. View

12.

Kupeli B, Irkilata L, Gurocak S, Tunc L, Kirac M, Karaoglan U . Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy?. Urology. 2004; 64(6):1111-5. DOI: 10.1016/j.urology.2004.07.020. View

13.

Sun X, He L, Ge W, Lv J . Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones. J Urol. 2009; 181(4):1716-20. DOI: 10.1016/j.juro.2008.11.118. View

14.

Porpiglia F, Ghignone G, Fiori C, Fontana D, Scarpa R . Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol. 2004; 172(2):568-71. DOI: 10.1097/01.ju.0000132390.61756.ff. View

15.

Trinchieri A, OSTINI F, Nespoli R, Rovera F, Montanari E, Zanetti G . A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol. 1999; 162(1):27-30. DOI: 10.1097/00005392-199907000-00007. View

16.

Weiss R, BASSETT A, Hoffman B . Adrenergic innervation of the ureter. Invest Urol. 1978; 16(2):123-7. View

17.

Lotan Y, Gettman M, Roehrborn C, Cadeddu J, Pearle M . Management of ureteral calculi: a cost comparison and decision making analysis. J Urol. 2002; 167(4):1621-9. View

18.

Autorino R, De Sio M, Damiano R, Di Lorenzo G, Perdona S, Russo A . The use of tamsulosin in the medical treatment of ureteral calculi: where do we stand?. Urol Res. 2005; 33(6):460-4. DOI: 10.1007/s00240-005-0508-0. View

19.

Dellabella M, Milanese G, Muzzonigro G . Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol. 2003; 170(6 Pt 1):2202-5. DOI: 10.1097/01.ju.0000096050.22281.a7. View

20.

Cervenakov I, Fillo J, Mardiak J, Kopecny M, Smirala J, Lepies P . Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker--Tamsulosin. Int Urol Nephrol. 2003; 34(1):25-9. DOI: 10.1023/a:1021368325512. View